Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors

Background: Fibrolamellar hepatocellular carcinoma (FLC) is a rare form of liver cancer primarily affecting children and young adults. Although considered a subset of hepatocellular carcinoma (HCC), FLC has unique molecular and pathologic characteristics, suggesting that it may require different tre...

Full description

Bibliographic Details
Main Authors:	Krista Y. Chen, Aleksandra Popovic, David Hsiehchen, Marina Baretti, Paige Griffith, Ranjan Bista, Azarakhsh Baghdadi, Ihab R. Kamel, Sanford M. Simon, Rachael D. Migler, Mark Yarchoan
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Cancers
Subjects:	fibrolamellar hepatocellular carcinoma liver cancer immune checkpoint inhibitor anti-PD-1 therapy
Online Access:	https://www.mdpi.com/2072-6694/14/21/5347

Similar Items

Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
by: Lafaro KJ, et al.
Published: (2015-10-01)

Multicentric Fibrolamellar Hepatocellular Carcinoma: A Rare Case Report
by: Mayank Goyal, et al.
Published: (2023-01-01)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
by: Nicolas A. Villa, et al.
Published: (2015-07-01)

Mixed fibrolamellar hepatocellular carcinoma
by: Faten Limaiem, et al.
Published: (2021-06-01)

Repeated metastasectomy in an adolescent with fibrolamellar hepatocellular carcinoma: A case report
by: Shaheed Merani, et al.
Published: (2016-05-01)

Fibrolamellar Carcinoma in a young patient
by: Javier Lizardi Cervera
Published: (2002-10-01)

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
by: Aline Lopes Chagas, et al.
Published: (2015-03-01)

Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database
by: Polychronidis G, et al.
Published: (2022-01-01)

Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
by: Ali AL Zahrani, et al.
Published: (2021-03-01)

Fibrolamellar Carcinoma: A Multimodal Approach
by: João Vasco Barreira, et al.
Published: (2020-04-01)

Fibrolamellar Hepatocellular Carcinoma: Report of a Rare Case with Rapid Progression and Unusual Metastatic Sites
by: Adeleh Rezagholizadeh Shirvan, et al.
Published: (2021-04-01)

Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
by: Seong Kyun Na
Published: (2022-09-01)

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
by: Gummadi J, et al.
Published: (2023-05-01)

Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
by: Pauline Gras, et al.
Published: (2012-04-01)

Utility of cytokeratin7 immunocytochemistry in the cytopathological diagnosis of fibrolamellar hepatocellular carcinoma
by: Rashi Garg, et al.
Published: (2018-01-01)

Extrahepatic transarterial radioembolization to treat fibrolamellar hepatocellular carcinoma: A case report
by: Damir Ljuboja, MD, MBA, et al.
Published: (2020-12-01)

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
by: Kastenhuber ER, et al.
Published: (2019-01-01)

Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma
by: Pattamon Sutthatarn, et al.
Published: (2021-03-01)

Fibrolamellar Carcinoma with DNAJB1-PRKACA Fusion in a 16-Year-Old: Case Report and Review of Literature
by: Varsha Prakash, et al.
Published: (2022-07-01)

An unusual cause of gastric extraluminal compression: fibrolamellar hepatocellular carcinoma
by: Dilettoso Salvatore, et al.
Published: (2013-04-01)

Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
by: Da Fonseca LG, et al.
Published: (2023-11-01)

Prognostic value of the proportion of the sclerosing component in fibrolamellar liver carcinoma
by: E. Yu. Antonova, et al.
Published: (2021-12-01)

Fibrolamellar hepatocellular carcinoma: a case report and gene analysis
by: Akira Watanabe, et al.
Published: (2023-09-01)

Fibrolamellar liver cancer: the modern concept
by: E. Yu. Antonova, et al.
Published: (2020-12-01)

Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
by: Wen Han, et al.
Published: (2023-05-01)

Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
by: Stefanie S. Schalm, et al.
Published: (2023-01-01)

DnaJ-PKAc fusion induces liver inflammation in a zebrafish model of fibrolamellar carcinoma
by: Sofia de Oliveira, et al.
Published: (2020-04-01)

An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
by: Rigney E Turnham, et al.
Published: (2019-05-01)

Identification of Long Non-Coding RNA Profiles and Potential Therapeutic Agents for Fibrolamellar Carcinoma Based on RNA-Sequencing Data
by: Janghyun Kim, et al.
Published: (2023-08-01)

Differential Diagnosis of Hepatic Mass with Central Scar: Focal Nodular Hyperplasia Mimicking Fibrolamellar Hepatocellular Carcinoma
by: Teodoro Rudolphi-Solero, et al.
Published: (2021-12-01)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
by: Bassem Shebl, et al.
Published: (2022-09-01)

Hepatocarcinoma fibrolamelar
by: Martín Ferreira Pozzi, et al.
Published: (2020-04-01)

Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma
by: Dominika Wolosz, et al.
Published: (2019-02-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
by: Ji Won Han, et al.
Published: (2021-09-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
by: Zhanjun Guo, et al.
Published: (2022-03-01)

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
by: Ramya Ephraim, et al.
Published: (2022-12-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
by: Federica Costa, et al.
Published: (2018-09-01)

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
by: Pei-Yi Chu, et al.
Published: (2021-10-01)

Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma
by: Alessandro Rizzo, et al.
Published: (2021-01-01)